BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15557445)

  • 1. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.
    Weinreb RN; Lindsey JD; Marchenko G; Marchenko N; Angert M; Strongin A
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4368-77. PubMed ID: 15557445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost.
    Weinreb RN; Lindsey JD
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):716-22. PubMed ID: 11867589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
    Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells.
    Anthony TL; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3705-11. PubMed ID: 12454040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of latanoprost acid and pilocarpine on cultured rabbit ciliary muscle cells.
    Zhong Y; Gao J; Ye W; Huang P; Cheng Y; Jiao Q
    Ophthalmic Res; 2007; 39(4):232-40. PubMed ID: 17622744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased human scleral permeability with prostaglandin exposure.
    Kim JW; Lindsey JD; Wang N; Weinreb RN
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1514-21. PubMed ID: 11381055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of scleral macromolecular permeability with prostaglandins.
    Weinreb RN
    Trans Am Ophthalmol Soc; 2001; 99():319-43. PubMed ID: 11797317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process.
    Husain S; Jafri F; Crosson CE
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1706-13. PubMed ID: 15851572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures.
    Wang N; Lindsey JD; Angert M; Weinreb RN
    Curr Eye Res; 2001 Mar; 22(3):198-207. PubMed ID: 11462156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone.
    el-Shabrawi Y; Eckhardt M; Berghold A; Faulborn J; Auboeck L; Mangge H; Ardjomand N
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():375-83. PubMed ID: 11027004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism.
    Hinz B; Rösch S; Ramer R; Tamm ER; Brune K
    FASEB J; 2005 Nov; 19(13):1929-31. PubMed ID: 16076963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of alpha2-adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body.
    Ooi YH; Oh DJ; Rhee DJ
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4237-43. PubMed ID: 19324857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta].
    Ke Y; Lu JH; Yang BL; Guo HQ; Ma QY; Zhu H; Shu HM; Li DJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):311-4. PubMed ID: 16762185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and their inhibitors as biomarkers for metal toxicity in vitro.
    Cammarota M; Lamberti M; Masella L; Galletti P; De Rosa M; Sannolo N; Giuliano M
    Toxicol In Vitro; 2006 Oct; 20(7):1125-32. PubMed ID: 16581223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin induces the expression of matrix metalloproteinase-1 in ciliary melanocytes.
    Wang NL; Lu QJ; Li JH; Wang L
    Chin Med J (Engl); 2008 Jul; 121(13):1173-6. PubMed ID: 18710634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea.
    Lopilly Park HY; Kim JH; Lee KM; Park CK
    Exp Eye Res; 2012 Jan; 94(1):13-21. PubMed ID: 22067128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of latanoprost and timolol on the histopathology of the human conjunctiva.
    Terai N; Schlötzer-Schrehardt U; Lampel J; Böhm AG; Rummelt C; Schmidt E; Pillunat LE
    Br J Ophthalmol; 2009 Feb; 93(2):219-24. PubMed ID: 18971237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.